Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-Week Phase II, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation

NCT01444131 is registered in ClinicalTrials.gov with University of Stellenbosch as lead sponsor.

NCT NCT01444131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01444131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-Week Phase II, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
Lead sponsor
University of Stellenbosch
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2013
Enrollment
446 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco dependence